Extended Windows in Acute Ischemic Stroke: What is the Time Limit?

“Time is brain” has traditionally guided acute ischemic stroke (AIS) management, with intravenous thrombolysis generally restricted to 4.5 hours and mechanical thrombectomy (MT) historically limited to selected patients within 6 hours. Advances in neuroimaging andendovascular therapy have demonstrated that tissue viability may be more important than elapsed time alone. This review examines contemporary therapeutic windows for acute cerebrovascular events and discusses how imaging-based selection has expandedopportunities for reperfusion therapy. Tissue-based thrombolysis using diffusion-weighted imaging–fluid-attenuated inversion (DWI-FLAIR) recovery mismatch or perfusion imaging has enabled treatment of selected patients with wake-up or unknown-onset stroke and those presenting 4.5–9 hours after last known well. Emerging evidence with tenecteplase suggests potential benefit in highly selected patients with large-vessel occlusion presenting up to 24 hours. Trials have now established substantial benefit in appropriately selected patients presenting 6–24 hours after last known well. Recent trials have further expanded thrombectomy eligibility to selected patients with large ischemic cores. Treatment beyond 24 hours remains investigational. Importantly, extended windows should not encourage treatment delays. Treatment decisions increasingly incorporate infarct-core size, collateral circulation, penumbral viability,occlusion site, clinical severity, pre-stroke functional status, and haemorrhagic risk. This paradigm is particularly relevant to resource-limited settings, where delayed presentation and interhospital transfer frequently prevent treatment within conventional windows. There is no single universal time limit for reperfusion therapy. The therapeutic window is increasingly determined by the interaction between time, tissue viability, and clinical factors, while earlier reperfusion remains preferable whenever feasible.

Authors

Institutions

Publication Details

Journal
Journal of Nepalese Society of Critical Care Medicine
Published
2026-11-12
DOI
https://doi.org/10.67570/jnsccm.v4i3.161
Primary Topic
Acute Ischemic Stroke Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Extended Windows in Acute Ischemic Stroke: What is the Time Limit?

Hemanshu Prabhakar
Journal of Nepalese Society of Critical Care Medicine
Acute Ischemic Stroke Management
article

Extended Windows in Acute Ischemic Stroke: What is the Time Limit?

Hemanshu Prabhakar
article en

Abstract

“Time is brain” has traditionally guided acute ischemic stroke (AIS) management, with intravenous thrombolysis generally restricted to 4.5 hours and mechanical thrombectomy (MT) historically limited to selected patients within 6 hours. Advances in neuroimaging andendovascular therapy have demonstrated that tissue viability may be more important than elapsed time alone. This review examines contemporary therapeutic windows for acute cerebrovascular events and discusses how imaging-based selection has expandedopportunities for reperfusion therapy. Tissue-based thrombolysis using diffusion-weighted imaging–fluid-attenuated inversion (DWI-FLAIR) recovery mismatch or perfusion imaging has enabled treatment of selected patients with wake-up or unknown-onset stroke and those presenting 4.5–9 hours after last known well. Emerging evidence with tenecteplase suggests potential benefit in highly selected patients with large-vessel occlusion presenting up to 24 hours. Trials have now established substantial benefit in appropriately selected patients presenting 6–24 hours after last known well. Recent trials have further expanded thrombectomy eligibility to selected patients with large ischemic cores. Treatment beyond 24 hours remains investigational. Importantly, extended windows should not encourage treatment delays. Treatment decisions increasingly incorporate infarct-core size, collateral circulation, penumbral viability,occlusion site, clinical severity, pre-stroke functional status, and haemorrhagic risk. This paradigm is particularly relevant to resource-limited settings, where delayed presentation and interhospital transfer frequently prevent treatment within conventional windows. There is no single universal time limit for reperfusion therapy. The therapeutic window is increasingly determined by the interaction between time, tissue viability, and clinical factors, while earlier reperfusion remains preferable whenever feasible.

Journal of Nepalese Society of Critical Care MedicineVol. 4(3)
All India Institute of Medical Sciences (IN)
Good health and well-being
Acute Ischemic Stroke Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon